First-line Gemcitabine Versus Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort Study.
Yamamoto S, Narui K, Ishikawa T, Adachi S, Shimada K, Shimizu D, Yamada A, Sugae S, Tanabe M, Oba M, Morita S, Doi T, Hasegawa S, Morita T, Kito A, Chishima T, Ichikawa Y, Endo I; YOKOHAMA CLINCAL ONCOLOGY GROUP.
Yamamoto S, et al. Among authors: shimada k.
Anticancer Res. 2021 Mar;41(3):1671-1676. doi: 10.21873/anticanres.14930.
Anticancer Res. 2021.
PMID: 33788764